Journals / Mikrobiyoloji Bülteni / 2003 / Cilt: 37 - Sayı: 4

Relapsing hepatitis A: Three case reports

Uzamış hepatit A: Üç olgu raporu

Pages
301–307
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, it was concluded that conservative follow-up and therapy would be sufficient since the prognosis of A hepatitis is usually benign even if it relapsed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this report, three patients, admitted to Ankara University Faculty of Medicine, Ibni Sina Hospital, Clinical Bacteriology and Infectious Diseases Department, with the diagnosis of acute viral hepatitis A have been discussed because of their clinical and/or biochemical relapses.
📊
Key Findings & Data:Follovving conservative treatment and bedrest, the liver transaminases decreased to nearly normal levels but a second peak was observed later in three of the cases.
💡
Conclusion & Impact:As a result, it was concluded that conservative follow-up and therapy would be sufficient since the prognosis of A hepatitis is usually benign even if it relapsed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tekrarlama · Tedavi sonucu · Hepatit A

Abstract

In this report, three patients, admitted to Ankara University Faculty of Medicine, Ibni Sina Hospital, Clinical Bacteriology and Infectious Diseases Department, with the diagnosis of acute viral hepatitis A have been discussed because of their clinical and/or biochemical relapses. Follovving conservative treatment and bedrest, the liver transaminases decreased to nearly normal levels but a second peak was observed later in three of the cases. Other viral, metabolic and autoimmune factors vvhich could lead to the increase of liver transaminases were ruled put. Anti-HAV IgM antibodies became negative in 2 to 4 months later, and liver enzymes returned to normal in 4 to 5 months after onset of their illnesses. As a result, it was concluded that conservative follow-up and therapy would be sufficient since the prognosis of A hepatitis is usually benign even if it relapsed.

Özet

Bu raporda, Ankara Üniversitesi Tıp Fakültesi İbn-i Sina Hastanesi Klinik Bakteriyoloji ve Enfeksiyon Hastalıkları Anabilim Dalı'nda klinik ve biyokimyasal bulgular ve hepatit A virüs (HAV) IgM pozitifliği ile akutviral hepatit A tanısı almış, ancak konservatif tedavi ve istirahat ile karaciğer enzimleri normal değerlere yaklaşırken ikinci kez yükselen üç hasta bildirilmektedir. Karaciğer transaminazlarını yükseltebilecek diğer viral, metabolik ve otoimmün nedenlerin ekarte edildiği üç olguda anti-HAV IgM 2 ila 4 ay sonra negatifleşmiş, karaciğer enzimleri ise 4 ila 5 ay içinde normal değerlere gerilemiştir. Sonuç olarak, nükslere rağmen A hepatitinin benign prognozu nedeniyle konservatif izlem ve tedavinin uygun olacağı düşünülmüştür.

🔖

Cite This Article

YEŞİLKAYA, A., DEMİR, G., MEMİKOĞLU, K. O., ÇOKÇA, F., SÖZEN, T. H. (2003). Relapsing hepatitis A: Three case reports. Mikrobiyoloji Bülteni, Cilt: 37 - Sayı: 4, 301–307. https://ajindex.com/articles/299439

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Koff RS: Viral hepatitis, pp:440-560. In: Schiff L, Schiff ER (Eds), Diseases of the Liver. 1993, 7th ed, JB Lippincott, Philadelphia
  2. Glikson M, Galun E, Oren R, Tur-Kapsa R, Shouval D: Relapsing hepatitis A: Review of 14 cases and literature survey. Medicine (Baltimore) 1992, 71: 14-23
  3. Vento S, Garofano T, Perri G, Dolci L, Concia E, Bassetti D: Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991, 337: 1183-1187, 4. Rahaman SM, Chira R Koff RS: Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastraenterol 1994, 89: 106-1 OB
  4. Inoue K, Yoshiba M, Yotsuyanagi H, Otsuka I Sekiyama K, Fujita R: Chronic hepatitis A with persistant viral replication. J Med Virol 1996, 50: 322-324
  5. Gordon SC, Rajender R, Schiff L, Schiff ER: Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann Intern Med 1984, 101: 635-637
  6. Jacobson IM, Nath BJ, Dienstag JL: Relapsing viral hepatitis type A. J Med Viral 1985, 16: 163-169
  7. Bornstein JD, Byrd DE, Trotter JF: Relapsing hepatitis A: A case report and review of the literature. J Clin Gastroenteroi 1999, 28: 355-356
  8. Gruer LD, McKendrick MW, Beeching NJ, Geddes AM: Relapsing hepatitis associated with hepatitis A virus. Lancet 1982, 2: 163 (letter), 10. Cuthbert JA: Hepatitis A: Old and new. Clin Microbiol Rev 2001, 14: 38-58
  9. RachimaCM, Cohen E, Garty M: Acute hepatitis A: Combination of the relapsing and the cholestatic forms, two rare variants. Am J Med Sci 2000, 319: 417-419
  10. Cobden L, James OF: A biphasic illness associated with acute hepatitis A virus infection. J Hepatol 1986, 2: 19-23
  11. Tong MJ, El-Farra NS, Grew Ml: Clinical manifestations of hepatitis A: Recent experience in a community teaching hospital. J Infect Dis 1995, 171(Suppl 1): S15-S18
  12. Fagan E, Yousef G, Brahm J, et al: Persistance of hepatitis A virus in fulminant hepatitis and after liver transplantation. J Med Virol 1990, 30: 131-136
  13. Sjogren MH, Tanno H, Fay O, et al: Hepatitis A virus in stool during clinical relapse. Ann Intern Med 1987, 106: 221-226
  14. Forbes A, Williams R: Changing epidemiology and clinical aspects of hepatitis A. Br Med Bull 1990, 46: 303-318
  15. Yotsuyanagi H, Koike K, Yasuda K, et al: Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by pdymerase chain reaction, Hepatobgy 1996, 24: 10-13
  16. Bamber M, Thomas HC, Bannister B, Sher